Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

被引：0
|
作者：
Jong, G. P. [1 ]
Yang, T. Y. [2 ]
机构：
[1] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Taichung, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Sodium-glucose Co-transporter 2 Inhibitors in Patients with Psoriasis and Concomitant Type 2 Diabetes Mellitus: A Population-based Cohort Study
    Huang, Pin-Chia
    Cheng, Debby
    Noe, Megan H.
    Lo, Jui-En
    Chen, Steven T.
    Ma, Kevin Sheng-Kai
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5041 - 5042
  • [22] Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes
    Matthews, David R.
    DIABETES OBESITY & METABOLISM, 2024, 26 : 3 - 4
  • [23] Sodium-glucose co-transporter-2 inhibitors and the risk of venous thromboembolism: A nationwide population-based study and meta-analysis
    Tsai, Hou-Ren
    Lin, Yu-Jie
    Yeh, Jih-, I
    Huang, Yu-Chi
    Liu, Peter Pin-Sung
    Peng, Carol Chiung-Hui
    Hsu, Jin-Yi
    Lee, Yuan-Chieh
    Loh, Ching-Hui
    Lin, Shu-Man
    Huang, Huei-Kai
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [24] Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study
    Schmedt, Niklas
    Enders, Dirk
    Walker, Jochen
    Garbe, Edeltraut
    Douros, Antonios
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (05): : 606 - +
  • [25] Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study
    Schmedt, Niklas
    Enders, Dirk
    Muller, Felix
    Walker, Jochen
    Garbe, Edeltraut
    Douros, Antonios
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 38 - 39
  • [26] Sodium-glucose co-transporter-2 inhibitors in Type 1 Diabetes: A Scoping Review
    Hropot, Tim
    Battelino, Tadej
    Dovc, Klemen
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 620 - 630
  • [27] Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?
    Czupryniak, Leszek
    Danne, Thomas
    Szymanska-Garbacz, Elektra
    Zozulinska-Ziolkiewicz, Dorota
    Gumprecht, Janusz
    Klupa, Tomasz
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 764 - 765
  • [28] Clinical use of sodium-glucose co-transporter-2 inhibitors in Chinese patients with type 2 diabetes mellitus
    Chan, Wing Bun
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (06) : 309 - 313
  • [29] Association between sodium-glucose co-transporter 2 inhibitors and risk of psoriasis in patients with diabetes mellitus: a nationwide population-based cohort study
    Ma, Sheng-Hsiang
    Wu, Chun-Ying
    Lyu, Ying-Syuan
    Chou, Yiing-Jenq
    Chang, Yun-Ting
    Wu, Chen-Yi
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (12) : 2242 - 2250
  • [30] Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes A Population-Based Cohort Study
    Fralick, Michael
    Chen, Sarah K.
    Patorno, Elisabetta
    Kim, Seoyoung C.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (03) : 186 - +
12345